Problems with PRISMA is a topic I hardly see talked or written about, even though the use of PRISMA has generated a lot of trouble in the recent scientific literature. PRISMA stands for Preferred Reporting Items for Systematic Reviews and Meta-Analyses, and refers to a set of standards that should be used when conducting a systematic review or meta-analysis, then publishing a report on it. PRISMA itself is not a bad thing, and the problems with PRISMA are not really PRISMA’s fault – they are with the inappropriate application of PRISMA.
The original intention of PRISMA was to provide guidance to epidemiologists like myself, who endeavor to write a review with the aim of synthesizing numerical results from high quality, large sample studies. A traditional scenario that is optimal for a PRISMA-style review is where a drug that treats a certain condition has been tested in the context of many different randomized controlled trials (RCTs), all of which report different effect sizes as results. Using PRISMA, appropriate RCTs can be selected for inclusion in the review, and their numerical results combined so that we can see at the end of the day what the overall effect is of this drug. If you are using PRISMA for that, I have no problems with PRISMA.
There is another scenario where PRISMA is also helpful, and that’s when a certain exposure (such as being exposed to pesticides as part of your job) is studied for its potentially harmful or protective effects (such as giving you cancer) over and over in different samples. This would be a longitudinal cohort study design, which is observational (not an RCT). Again, each study would calculate a different effect size, and so how do you put them all together and see what the overall effect of the exposure is on the resulting condition? PRISMA to the rescue. Again, in this case, I have no problems with PRISMA being used.
In fact, I am first author of a systematic review like that published in 2009, where our research team examined whether a woman being pregnant changed her metabolism in such a way that it granted her protection from pancreatic cancer (spoiler: it didn’t). I didn’t use PRISMA for this because the first version of PRISMA was published the same year, but had it been around at the time we did the review, we could have applied the standards, and would have had no problems with PRISMA.
Problems with PRISMA: So What’s Wrong with it?
The problem comes with applying PRISMA to do a review in any other situation. Starting about 10 years ago, I was surprised to start seeing PRISMA reviews that included articles on studies that were not biomedical in nature. These articles did not report RCTs or cohort studies. They often reported cross-sectional studies, which are a relatively weak form of evidence (with respect to the evidence-based medicine framework), as I will depict in a figure below.
As you can see by the graphic above, most study designs are not rigorous enough to be included in a PRISMA review. I’m not sure why, but the organization that developed PRISMA actually started promoting the use of low-rigor study designs in PRISMA reviews about 10 years ago. Next, researchers actually started doing PRISMA reviews with low-rigor study designs, and professors began encouraging students to create and publish PRISMA reviews with low-rigor study designs. So what was the result of all this?
The Scientific Literature Explodes with Useless PRISMA Reviews
As you can probably guess, if you use a screwdriver to do something that requires a hammer, you will not get good results. So if you try to apply PRISMA to low-rigor study designs, you are going to get a bunch of crappy review papers.
Take, for example, this systematic review of the impact of social support on college students’ wellbeing and mental health. “Social support” is not a drug or a biological exposure, and “wellbeing and mental health” is not a specific condition. How can a study like this combine effect sizes from different studies when the studies are going to measure these latent variables so differently?
If you download the paper, you will see the PDF is 20 pages long, but the results are only on pages 7 through 12. What’s before that is mostly methods, which is boring in this context. Most of the methods in PRISMA have to do with assessing the quality of the rigor of the included studies – which is already low if they are not RCTs or cohort studies, which is the case in this and many other recent PRISMA reviews.
The article says that numerical results could not be synthesized because of the diversity of study designs and measurements across the 51 studies they included. Obviously! So the article instead tallies the years in which they were published (with several years having only one study published), the countries where the studies were conducted (with seven countries only contributing one study), and the various instruments used for measuring wellbeing and social support. The authors are left with reporting on three topics they call “themes” across the studies: instruments used to measure wellbeing and social support, direct effects of social support on wellbeing, and indirect effects of social support on wellbeing.
I am not picking on these authors – all the PRISMA-style articles including low-rigor studies read like this. They take a collection of articles that meet some qualification criteria, and try to find some similarities across them. The result is an article of no use to the scientific literature. As a scientific author, I cannot cite this article for any reason, because it does not report any findings relevant to science. So why do so many of these articles exist and clutter up the scientific literature?
Why Useless PRISMA Reviews are Published
The answer is simple. Authors write them just so they can say they have a publication. After all, they don’t have to go through the trouble of actually doing a study themselves. They can just come up with some topic, get a bunch of articles on the topic, put them through the PRISMA machine, and viola! A publishable paper. The journals accept them because PRISMA is considered a scientifically rigorous way of doing reviews. So the journal gets its publication fee, and the authors get another publication for their CVs.
So Should We Stop Doing Review Papers?
Absolutely not! In fact, I would argue that these same authors could have done a different type of review of the 51 studies they included that would have produced knowledge that was useful to the body of scientific literature, and would have been citable.
The point of this blog post is to enlighten you to the fact that there are other types of reviews that can be done that are not PRISMA reviews, and are more suitable for topics like social support and wellbeing. Because there is a diversity of nomenclature in naming these different review styles, I will refer to this paper, which provides guidance on what types of reviews exist and how they are done.
I will highlight a few types of reviews the authors talk about in this paper that would have been better alternatives to PRISMA for summarizing studies that are low on the evidence-based medicine pyramid. Rather than talking about review styles, they collect similar review styles into what they call “families” of reviews, several of which I will talk about here.
Traditional Reviews Family
These are reviews that summarize the literature after applying purposive sampling, which means setting qualification criteria and making sure all the articles included in the review meet those criteria. While this happens in PRISMA, PRISMA requires a lot of other processes that are not required of traditional reviews.
In one type of traditional review which I find particularly useful, the articles are summarized using a narrative review approach. Examples I have co-authored include one on periodontitis in Saudi Arabia, and one on deeper learning methods and modalities in higher education.
This approach would have probably been more useful for the social support and wellbeing/mental health review I mentioned earlier. Using a traditional narrative review, the authors could have still sampled the 51 studies they used, but they would not have had to spend a lot of extra real estate on explaining their methodology. Instead, they could have dug more into what the articles actually said. They might have grouped the articles by similarities in their study designs, and then summarized what those groups of articles found. In any case, an alternative review approach could have freed the authors to generate and present true higher-level knowledge from considering what the articles said collectively.
Purpose-specific Reviews Family
To explain this family of reviews, it’s best that I quote the authors:
The purpose-specific review family is the most difficult to characterize largely because of the heterogeneity of review types and methods. All review types should be selected appropriately according to purpose; however, by “purpose-specific” we imply that the degree of tailoring required to meet a specific single purpose is such that it makes it more challenging to adapt the review type for generic use beyond that purpose.
The authors give the example of a health technology assessment, where specific questions need to be answered as part of the review. Scoping reviews fall under this family.
Systematic Reviews Family
These are where the PRISMA reviews fall, but the paper points out there are other standards that can be followed for systematic reviews.
Rapid Reviews Family
You may have seen “rapid review” in the title of some reviews. The authors describe this family of reviews this way:
All rapid reviews should involve detailed negotiation between the review team and the client/customer regarding the scope and methods to establish how they will be delivered within the time available; this negotiation is the defining feature of this family.
How I read this is that every “rapid review” published is based on a negotiation between the authors and the journal as to how and what the authors cover. Indeed, it has been my experience that journals often reach out to authors known to be experts in their field and ask them to undertake a rapid review on an emerging topic.
Qualitative Systematic Reviews Family
These are reviews of qualitative studies. While it is certainly acceptable to write a review of qualitative studies, I strongly caution against engaging in a qualitative evidence synthesis (QES), which is one type of review in this family. This is because qualitative studies are not designed to be synthesized together like quantitative studies; they are meant to be unique and connected directly to their original context, and the QES violates this standard by employing an approach parallel to combining numerical estimates as is done in a meta-analysis.
Are There Other Review Approaches Not Mentioned Here?
Yes! There are many different ways to approach reviewing a body of literature. I encourage you to read the original article to which I’m referring. If you do that, you will find that even though the article does a good job of summarizing the types of reviews out there, it takes care to point out that there is a diversity in the language used around these different types of reviews, and unlike PRISMA, many do not have well-established processes and standards.
My overall point is to avoid using PRISMA to guide your review unless your research question can be answered by filtering in RCTs or cohort studies on the topic, and is aimed at estimating an overall effect size. If the types of studies you want to include in your review have a low level of rigor, instead, consider an alternative approach, such as a traditional narrative review with purposive sampling, or one of the other review types mentioned in the article I cited.
Read all of our data science blog posts!
Problems with PRISMA? You’re not the only one. The PRISMA framework does not work well for most reviews. Read my blog post to learn what you should do instead.

